Skip to main content
. 2014 Jun 18;348:g3769. doi: 10.1136/bmj.g3769

Table 2.

 Baseline characteristics of attention-deficit/hyperactivity patients according to treatment patterns. Values are numbers (percentages) unless stated otherwise

Characteristic No treatment (n= 14 485) Intermittent treatment (n= 21 174) Continuous treatment (n= 2277)
Female sex 4450 (30.7) 7531 (35.6) 566 (24.9)
Median (interquartile range) age, years 19 (15-26) 17 (13-28) 14 (12-20)
Younger cohort born during 1982-96 10 241 (70.7) 14 548 (68.7) 1850 (81.3)
Older cohort born during 1960-81 4244 (29.3) 6626 (31.3) 427 (18.8)
At least one suicide related event 1059 (7.3) 2097 (9.9) 107 (4.7)
Use of drugs during follow-up:
 At least one stimulant treatment period 19 814 (93.6) 2233 (98.1)
 At least one non-stimulant treatment period 4896 (23.1) 486 (21.3)
 At least one prescription for antidepressant 5094 (35.2) 9430 (44.5) 705 (31.0)
Comorbid conditions before or during follow-up:
 Depressive disorder 3292 (22.7) 5584 (26.4) 357 (15.7)
 Bipolar affective disorder 821 (5.7) 1493 (7.1) 92 (4.0)
 Conduct disorder 745 (5.1) 1310 (6.2) 165 (7.3)
 Drug abuse 2116 (14.6) 3854 (18.2) 165 (7.3)
 Borderline personality disorder 619 (4.3) 1137 (5.4) 60 (2.6)